TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
KRYS

Krystal Biotech Inc

Healthcare · Biotechnology

336.70$ -0.6% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Balance Sheet

Krystal Biotech Inc (KRYS) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 1,334 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet KRYS
Line item 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
2.2 50 116 209 311 626 558 818 1,056 1,334
2.2 50 113 196 275 442 384 588 742 1,025
1.9 50 104 188 268 341 162 358 345 496
1.9 50 112 194 271 438 379 532 598 828
0.0 42 105 127
0.0 0.0 7.0 27 40
0.0 0.2 3.0 11 31 120 170
0.0
0.0
1.9 0.6 2.9 6.1 19 33 36 40 109 114
0.0 0.6 2.6 3.3 15 26 29 33 102 103
0.0 0.5 8.2 1.0 1.6 1.5 1.2 1.8
0.0 0.2 0.9 1.0 2.1 8.4 4.0 1.8 5.0 3.2
1.8 0.0
0.3 49 113 203 292 594 522 779 946 1,220
-1.2 -9.1 -20 -39 -71 -141 -281 -270 -181 24
4.3 5.4 11 16 19 22 25 28 30 30

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?